Within a cellular clinical viewpoint, Relafen 750 (Naproxen) exhibits particular behaviors. It works primarily as a cyclooxygenase medication , largely inhibiting cyclooxygenase-2 (COX-2), an catalyst involved in prostaglandin formation. This targeted inhibition leads to reduced inflammation and pain , offering clinical benefits for subjects experi